Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 17 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-2.20 Insider Own19.84% Shs Outstand75.98M Perf Week-8.83%
Market Cap700.20M Forward P/E- EPS next Y-2.16 Insider Trans-0.34% Shs Float63.93M Perf Month-38.69%
Income-183.26M PEG- EPS next Q-0.59 Inst Own92.88% Short Float21.90% Perf Quarter-33.48%
Sales0.00M P/S- EPS this Y-17.63% Inst Trans-2.45% Short Ratio15.57 Perf Half Y-52.69%
Book/sh2.29 P/B3.83 EPS next Y7.89% ROA-62.98% Short Interest14.00M Perf Year3.66%
Cash/sh2.99 P/C2.94 EPS next 5Y- ROE-89.09% 52W Range5.93 - 21.17 Perf YTD-53.30%
Dividend Est.- P/FCF- EPS past 5Y8.79% ROI-79.76% 52W High-58.53% Beta0.87
Dividend TTM- Quick Ratio6.58 Sales past 5Y-5.25% Gross Margin- 52W Low48.06% ATR (14)0.82
Dividend Ex-Date- Current Ratio6.58 EPS Y/Y TTM23.04% Oper. Margin0.00% RSI (14)25.27 Volatility8.48% 8.72%
Employees150 Debt/Eq0.33 Sales Y/Y TTM-100.00% Profit Margin- Recom1.00 Target Price26.50
Option/ShortYes / Yes LT Debt/Eq0.26 EPS Q/Q-19.87% Payout- Rel Volume1.68 Prev Close9.45
Sales Surprise- EPS Surprise-22.10% Sales Q/Q- EarningsMay 07 BMO Avg Volume899.63K Price8.78
SMA20-14.10% SMA50-30.66% SMA200-31.95% Trades Volume1,511,691 Change-7.09%
Date Action Analyst Rating Change Price Target Change
Mar-28-24Initiated Raymond James Strong Buy $30
Oct-25-23Upgrade Jefferies Hold → Buy $20
Apr-03-23Resumed Piper Sandler Overweight $26
Sep-19-22Resumed H.C. Wainwright Buy $30
Jul-12-22Initiated Truist Buy $20
Mar-23-22Initiated H.C. Wainwright Buy $24
Dec-22-21Downgrade Jefferies Buy → Hold $52 → $28
Nov-19-21Initiated Piper Sandler Overweight $56
Apr-26-21Resumed Credit Suisse Outperform $65
Jan-11-21Initiated Credit Suisse Outperform $65
Jun-03-24 04:00PM
May-28-24 08:00AM
May-22-24 07:00AM
May-20-24 08:00AM
May-17-24 04:15PM
08:00AM Loading…
May-14-24 08:00AM
May-07-24 01:53PM
Apr-24-24 06:33AM
Apr-12-24 04:15PM
Mar-20-24 05:31AM
Mar-19-24 10:52PM
04:15PM Loading…
Mar-15-24 04:15PM
Feb-28-24 08:00AM
Feb-16-24 04:15PM
Feb-15-24 08:00AM
Feb-06-24 08:00AM
Jan-25-24 08:00AM
Jan-23-24 08:00AM
Jan-22-24 07:00AM
Jan-18-24 05:01PM
Jan-12-24 04:15PM
Jan-04-24 08:00AM
Jan-02-24 01:57PM
Dec-30-23 07:01PM
Dec-19-23 08:00AM
04:15PM Loading…
Dec-15-23 04:15PM
Dec-10-23 09:05AM
Nov-17-23 04:15PM
Nov-12-23 12:32PM
Nov-07-23 08:14AM
Nov-06-23 09:55AM
Nov-03-23 11:52PM
Nov-02-23 08:00AM
Oct-31-23 08:50AM
Oct-24-23 12:00PM
Oct-23-23 08:00AM
Oct-19-23 09:55AM
Oct-18-23 08:30AM
Oct-16-23 04:15PM
Oct-13-23 12:45PM
Oct-12-23 04:17PM
Oct-11-23 08:57PM
Sep-19-23 08:00AM
Sep-15-23 04:15PM
Sep-07-23 09:55AM
Aug-18-23 04:15PM
Aug-09-23 04:15PM
Aug-02-23 10:41AM
Jul-13-23 08:00AM
Jun-30-23 11:00AM
Jun-15-23 08:00AM
Jun-01-23 04:05PM
May-10-23 08:00AM
May-09-23 07:30AM
May-08-23 08:00AM
Apr-17-23 12:57PM
Apr-12-23 08:00AM
Apr-10-23 04:05PM
Mar-15-23 08:00AM
Mar-07-23 07:00AM
Mar-01-23 08:00AM
Feb-27-23 08:00AM
Feb-17-23 08:00AM
Feb-11-23 07:23AM
Feb-06-23 08:00AM
Jan-09-23 08:00AM
Jan-03-23 08:00AM
Nov-16-22 06:04AM
Nov-15-22 08:00AM
Nov-14-22 08:00AM
Nov-10-22 09:00AM
Nov-09-22 08:00AM
Nov-08-22 08:00AM
Oct-22-22 07:00AM
Oct-06-22 08:00AM
Oct-04-22 08:00AM
Sep-22-22 04:15PM
Sep-20-22 07:00AM
Sep-19-22 02:39PM
Sep-16-22 08:30AM
Sep-04-22 08:09AM
Aug-08-22 04:15PM
Jul-25-22 07:14AM
Jul-19-22 07:30AM
Jul-15-22 08:00AM
Jul-11-22 09:55AM
Jul-01-22 04:00PM
Jun-27-22 04:06PM
Jun-24-22 09:55AM
Jun-17-22 11:28AM
Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the business of discovering, developing, and delivering innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Backstrom Jay T.CHIEF EXECUTIVE OFFICERFeb 16 '24Sale15.7411,614182,842352,671Feb 20 04:46 PM
Myles Edward HCOO & CFOFeb 16 '24Sale15.744,74474,686210,976Feb 21 06:13 PM
Parlavecchio CarynCHROFeb 16 '24Sale15.743,75159,053157,744Feb 20 04:52 PM
Ho JunlinGENERAL COUNSELFeb 16 '24Sale15.743,48954,928208,771Feb 20 04:48 PM
Qatanani MoCHIEF SCIENTIFIC OFFICERFeb 16 '24Sale15.742,51239,547147,019Feb 20 04:58 PM
Myles Edward HCOO & CFOJan 16 '24Sale15.936,634105,670162,150Jan 18 04:07 PM
Ho JunlinGENERAL COUNSELJan 16 '24Sale15.934,18666,677154,405Jan 18 04:05 PM
Parlavecchio CarynCHROJan 16 '24Sale15.932,84945,381114,350Jan 18 04:08 PM
Qatanani MoSVP AND HEAD OF RESEARCHJan 16 '24Sale15.932,00231,88978,816Jan 18 04:11 PM
Myles Edward HCOO & CFODec 29 '23Option Exercise4.8612,45960,551181,243Dec 29 07:13 PM
Myles Edward HCOO & CFODec 29 '23Sale18.8312,459234,633168,784Dec 29 07:13 PM
Qatanani MoSVP AND HEAD OF RESEARCHDec 14 '23Option Exercise10.008,43784,370105,480Dec 15 04:13 PM
Qatanani MoSVP AND HEAD OF RESEARCHDec 14 '23Sale18.1824,662448,44480,818Dec 15 04:13 PM
Myles Edward HCOO & CFODec 07 '23Option Exercise4.8624,914121,082193,698Dec 08 04:12 PM
Myles Edward HCOO & CFODec 07 '23Sale17.5324,914436,820168,784Dec 08 04:12 PM
Myles Edward HCOO & CFONov 02 '23Sale12.5135,007438,039168,784Nov 03 06:11 PM
AKKARAJU SRINIVASDirectorOct 16 '23Buy6.852,189,78115,000,0006,788,609Oct 18 05:46 PM
Samsara BioCapital GP, LLC10% OwnerOct 16 '23Buy6.852,189,78115,000,0006,788,609Oct 18 05:44 PM
Invus Public Equities, L.P.10% OwnerOct 12 '23Buy6.862,199,93115,086,73611,259,438Oct 16 05:46 PM
Qatanani MoSVP AND HEAD OF RESEARCHSep 18 '23Sale6.341,94512,33197,043Sep 20 07:28 PM
Parlavecchio CarynCHROAug 16 '23Sale6.831,3539,241117,199Aug 18 04:05 PM